Korea S.E.
23:00:00 04/07/2024 BST
5-day change
1st Jan Change
5,460
KRW
+0.37%
-1.62%
-23.96%
Tranche Update on Korean Drug Co., Ltd.'s Equity Buyback Plan announced on December 11, 2018.
March 11, 2019 at 07:05 am
From January 1, 2019 to March 6, 2019, the company has repurchased 10,000 shares, representing 0.09% for KRW 83.11 million. With this, the company has completed the repurchase of 20,000 shares, representing 0.18% for KRW 152.32 million under the buyback announced on December 11, 2018.
Korean Drug Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
15/05/23
CI
Tranche Update on Korean Drug Co., Ltd.'s Equity Buyback Plan announced on December 14, 2020.
02/03/21
CI
Tranche Update on Korean Drug Co., Ltd.'s Equity Buyback Plan announced on December 14, 2020.
02/03/21
CI
Korean Drug Co., Ltd.'s Equity Buyback announced on December 14, 2020, has closed with 14,000 shares, representing 0.13% for KRW 143.66 million.
25/02/21
CI
Korean Drug Co., Ltd. announces an Equity Buyback for 14,000 shares.
14/12/20
CI
Korean Drug Co., Ltd. authorizes a Buyback Plan.
13/12/20
CI
Tranche Update on Korean Drug Co., Ltd.'s Equity Buyback Plan announced on December 11, 2018.
11/03/19
CI
Tranche Update on Korean Drug Co., Ltd.'s Equity Buyback Plan announced on December 11, 2018.
11/03/19
CI
Korean Drug Co., Ltd.’s Equity Buyback announced on December 11, 2018 has closed with 20,000 shares, for KRW 152.32 million.
05/03/19
CI
Korean Drug Co., Ltd. announces an Equity Buyback for 20,000 shares.
10/12/18
CI
Korean Drug Co. Ltd. authorizes a Buyback Plan.
10/12/18
CI
Tranche Update on Korean Drug Co. Ltd.'s Equity Buyback Plan announced on March 8, 2016.
06/06/16
CI
Korean Drug Co. Ltd.'s Equity Buyback announced on March 8, 2016 has closed with 15,000 shares, representing 0.14% for KRW 104.64 million.
01/06/16
CI
Korean Drug Co. Ltd. announces an Equity Buyback for 15,000 shares.
07/03/16
CI
Korean Drug Co. Ltd. authorizes a Buyback Plan.
07/03/16
CI
Tranche Update on Korean Drug Co. Ltd.'s Equity Buyback Plan announced on November 10, 2014.
08/02/15
CI
Korean Drug Co. Ltd.'s Equity Buyback announced on November 10, 2014 has closed with 20,000 shares, representing 0.18% for KRW 82.6 million.
01/02/15
CI
Korea Securities Finance Corporation acquired 3.64% stake in Korean Drug Co. Ltd..
09/01/15
CI
Korean Drug Co. Ltd. announces an Equity Buyback for 20,000 shares.
09/11/14
CI
Korean Drug Co. Ltd. authorizes a Buyback Plan.
09/11/14
CI
Korea Securities Finance Corporation, Investment Arm acquired a 4.2% stake in Korean Drug Co. Ltd..
11/04/14
CI
Tranche Update on Korean Drug Co. Ltd.'s Equity Buyback Plan announced on September 3, 2013.
01/12/13
CI
Korean Drug Co. Ltd.’s Equity Buyback announced on September 3, 2013 has closed with 53,000 shares, representing 0.47% for KRW 170.43 million.
26/11/13
CI
Korean Drug Co. Ltd. authorizes a Buyback Plan.
02/09/13
CI
Korean Drug Co. Ltd. announces an Equity Buyback for 53,000 shares.
02/09/13
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
KOREAN DRUG CO.,LTD is a Korea-based company engaged in the manufacture and distribution of pharmaceuticals. The Companyâs products portfolio consists of over-the-counter (OTC) medicines, ethical (ETC) medicines and health food, including multi-symptom cold medicines, blood-forming nutrients, treatments for central nervous system, remedies for respiratory diseases, dermatological agents, vitamins, antifungal agents, antipyretics, analgesics, anti-inflammatory drugs, antibiotics, allergic treatments, calcium and vitamin D tablets and home pregnancy test kits, among others.
More about the company
1st Jan change
Capi.
-23.96% 43.18M +24.53% 45.07B +30.99% 23.39B +24.13% 16.08B +21.15% 14.6B +68.67% 14.01B -0.05% 6.79B -13.29% 6.38B -8.87% 5.73B +13.53% 5.64B
Generic Pharmaceuticals
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
KOREAN DRUG CO., LTD. 
